CXCL12 and bone cancer: In bone cancer pain model, CXCL12 expression was upregulated in the DRG and spinal cord after tumor cell implantation (TCI) and repeated administration of AMD3100 significantly delayed and suppressed the initiation and persistence of bone cancer pain13.